Evidence map›Paper›PMID 31697957›Full record

ReviewAntiviral research2019

2019 meeting of the global virus network.

Ramesh Akkina, Robert Garry, Christian Bréchot, Heinz Ellerbrok, Hideki Hasegawa, Luis Menéndez-Arias, Natalia Mercer, Johan Neyts, Victor Romanowski, Joaquim Segalés and 1 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Antiviral research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ramesh AkkinaColorado State University. Microbiology, Immunology and Pathology, USA.
Robert GarryTulane University, New Orleans, LA, USA.
Christian BréchotGlobal Virus Network, Baltimore, MD, USA.
Heinz EllerbrokRobert Koch Institute. Center for International Health Protection, Germany.
Hideki HasegawaNational Institute of Infectious Diseases. Department of Pathology, Japan.
Luis Menéndez-AriasCentro de Biología Molecular Severo Ochoa, Spain.
Natalia MercerGlobal Virus Network, Baltimore, MD, USA.
Johan NeytsRega Institute for Medical Research, University of Leuven, Belgium.
Victor RomanowskiUniversidad Nacional de La Plata. IBBM, Facultad de Ciencias Exactas, Argentina.
Joaquim SegalésDepartament de Sanitat i Anatomia Animals, Facultat de Veterinària, Universitat Autònoma de Barcelona, and Centre de Recerca en Sanitat Animal (CReSA, IRTA-UAB), UAB, Bellaterra, Spain.
Anders VahlneKarolinska Institutet, Stockholm, Sweden; Global Virus Network, Baltimore, MD, USA. Electronic address: Anders.Vahlne@ki.se.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Global Virus Network (GVN) was established in 2011 to strengthen research and responses to emerging viral causes of human disease and to prepare against new viral pandemics. There are now 52 GVN Centers of Excellence and 9 Affiliate laboratories in 32 countries. The 11th International GVN meeting was held from June 9-11, 2019 in Barcelona, Spain and was jointly organized with the Spanish Society of Virology. A common theme throughout the meeting was globalization and climate change. This report highlights the recent accomplishments of GVN researchers in several important areas of medical virology, including severe virus epidemics, anticipation and preparedness for changing disease dynamics, host-pathogen interactions, zoonotic virus infections, ethical preparedness for epidemics and pandemics, one health and antivirals.

Indexed as

Communicable Diseases, EmergingGlobal HealthVirus DiseasesAnimalsAntiviral AgentsArbovirusesClimate ChangeCoronavirusEbolavirusHemorrhagic Fever, EbolaHepatitis BHost-Pathogen InteractionsHumansInfluenza, HumanInternationalityOne HealthAntiviral AgentsViral VaccinesClimate changeEmerging virusesGlobalizationGlobal virus networkPandemic

Identifiers

PMID31697957
PMCPMC7127664

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.